Guardant Health Inc (NAS:GH)
$ 23.42 -0.18 (-0.76%) Market Cap: 2.88 Bil Enterprise Value: 3.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 07:30PM GMT
Release Date Price: $77.54 (-1.16%)
Tejas Rajeev Savant
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. My name is Tejas Savant, and I work on the Life Sciences team at JPMorgan. It's my pleasure this morning to introduce Helmy Eltoukhy, CEO and Founder of Guardant Health. At the end of Helmy's presentation, there will be a breakout with management in the Olympic Room.

And with that, I'd like to hand it over to Helmy.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Thank you, Tejas. It's always exciting to be here, and thank you for the invitation this week. Please note our forward-looking statement.

When we started Guardant several years ago, we were frustrated by the slow rate of progress in health care, and more specifically, oncology. We believe that this fundamentally came down to a lack of data, data that was largely locked away inside tumor tissue, serving as a bottleneck to our collective understanding of how tumors grow, evolve and change over time, and especially in response to applied interventions. We believe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot